~~<i id='22FE01CAD3'><strike id='22FE01CAD3'><tt id='22FE01CAD3'><pre id='22FE01CAD3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：hotspot 2025-08-19 12:10:25 - browse：9

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Use doctors trained outside the U.S. to ease the physician shortage

entertainment

hotspot

focus

explore

Wikipedia

hotspot

JohnLocher/APPresidentTrump’srevelationthisweekthathe’stakinghydroxychloroquinetowardoffCovid-19sent

WSS

CDC says it’s too soon to assess risk posed by Covid subvariant

CDC says it’s too soon to assess risk posed by Covid subvariant

Dexcom's push to bring CGM to type 2 diabetes patients

How to make over

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Beware reading your test results before your doctor does

hotspot

hotspot

entertainment

Medical leaders decry Supreme Court decision on affirmative action

What affirmative action's end means to a medical student

Virginia high school admissions case could be legal follow

What affirmative action's end means to a medical student

In Memoriam: Notable people who died in 2023

As obesity drug market grows, telehealth companies court payers

New air purifier tech could be key to improving indoor air quality

How to make over

Drug repurposing or repositioning? The language matters

Vivek Ramaswamy made waves in the debate, much as in biotech

hotspot

Beware reading your test results before your doctor does

CDC says it’s too soon to assess risk posed by Covid subvariant

Meadows told special counsel he could not recall Trump ever declassifying Mar

Kellogg’s is going to war over Mexico’s nutrition label rules

Vertex cell therapy lets patients with type 1 diabetes stop insulin

People can get long Covid without testing positive for virus: Study

focus

explore

Wikipedia

hotspot